Market Overview

BMO Capital Maintains Outperform on Celgene Corporation, Raises PT to $113.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for CELG

DateFirmActionFromTo
Jul 2015Morgan StanleyMaintainsEqual-weight
Jul 2015Canaccord GenuityMaintainsBuy
Jul 2015Piper JaffrayMaintainsOverweight

View More Analyst Ratings for CELG
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (CELG)

Get Benzinga's Newsletters